Диссертация (1141110), страница 25
Текст из файла (страница 25)
- № 4. - Р. 408-411.68.Cherqui, D. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, andpathological correlations / D . Cherqui et al. // Hepatology. - 1995. - V. 22. - №6. - Р. 1674-1681.69.Choi, C.S. Triphasic helical CT of hepatic focal nodular hyperplasia: incidenceof atypical findings / C.S. Choi, P.C. Freeny // AJR Am J Roentgenol. – 1998. V. 170.
- № 2. - Р. 391-395.70.Cho, C.S. A novel prognostic nomogram is more accurate than conventionalstaging systems for predicting survival after resection of hepatocellular carcinoma / C.S. Cho et al. // J Am Coll. Surg. - 2008. - V. 206. - Р. 281-291.71.Choi, J.-Y. CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I.
Development, Growth, and Spread: Key Pathologic and Imaging Aspects / J.-Y. Choi, J.-M. Lee, C.B. Sirlin // Radiology. - 2014. - V. 272.- № 3. - Р. 635–654.72.Chung, Y.E. Hepatocellular carcinoma variants: radiologic-pathologic correlation / Y.E. Chung et al. // AJR. - 2009. - V. 193. - Р. 7-13.73.Cucchetti, A. Simultaneous presence of focal nodular hyperplasia and hepatocellular carcinoma: case report and review of the literature / A.
Cucchetti et al.// Tumori. – 2003. - V. 89. - № 4. - Р. 434-436.74.Di Stasi, M. Natural history of focal nodular hyperplasia of the liver: an ultrasound study / M. Di Stasi et al. // J Clin Ultrasound. – 1996. – V. 24. - № 7. –Р. 345-350.16575.Di Martino, M. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings / M. Di Martino et al. // Eur.
Radiol.- 2014. - V. 24. - Р. 1446-1454.76.El-Assal, O.N. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surroundingliver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver / O.N. El-Assal et al. // Hepatology. - 1998. - V. 27. P. 1554-1562.77.European association for the study of the liver; European organisation for research and treatment of cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma // J.
Hepatol. - 2012. - V. 56. P. 908-943.78.Fernandez, M. Angiogenesis in liver disease / Fernandez M. et al. // J. Hepatol.- 2009. - V.50. - P. 604-620.79.Folberg, R. Vasculogenic mimicry and tumor angiogenesis / R. Folberg, M.J.Hendrix, A.J. Maniotis // Am. J. Pathol. - 2000. - V.156. - P.
361-381.80.Folkman, J. What is the evidence that tumors are angiogenesis dependent? / J.Folkman // J. Natl. Cancer Inst. - 1990. - V.82. - P. 4-6.81.Folkman, J. Angiogenesis: an organizing principle for drug discovery? / J.Folkman // Nature Reviews Drug Discovery. - 2007. - V. 6. - № 4. - Р. 273286.82.Fong, Z.V. The clinical management of hepatocellular carcinoma in the UnitedStates, Europe, and Asia: a comprehensive and evidence-based comparison andreview / Z.V.
Fong, K.K. Tanabe // Cancer. – 2014. – V.120. - № 18. P. 28242838.83.Fonseca, A.L. Hepatocellular carcinoma: a comprehensive overview of surgical therapy / A.L. Fonseca, C.H. Cha // J. Surg. Oncol. - 2014. V. 110. - № 6. P. 712-719.16684.Fowler, K.J. Magnetic resonance imaging of focal liver lesions: approach toimaging diagnosis / K.J. Fowler, J.J. Brown, V.R. Narra // Hepatology. - 2011.- V.
54. - № 6. - P. 2227-2237.85.Freeny, P.C. Hepatic hemangioma: dynamic bolus CT / P.C. Freeny, W.M.Marks // AJR Am J Roentgenol. - 1986. - V. 147. - Р. 711-719.86.Freeny, P.C. Significance of hyperattenuating and contrast-enhancing hepaticnodules detected in the cirrhotic liver during arterial phase helical CT in preliver transplant patients: Radiologic-histopathologic correlation of explantedlivers / P.C.
Freeny et al. // Abdom Imaging. - 2003. - V. 28. - № 3. - Р. 333346.87.Fukumura, D. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma / D. Fukumura et al. // Am. J. Pathol. - 1997. V.151. - P. 679-688.88.Gaddikeri, S. Hepatocellular carcinoma in the noncirrhoticlive / S. Gaddikeri etal. // Am. J. Roentgenol. - 2014. - V. 203. - № 1.
- Р. 34-47.89.Gaiani, S. Usefulness of contrastenhancedperfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography / S. Gaiani et al. // J. Hepatol. - 2004. - V. 41. - № 3. - Р. 421-426.90.Grazioli, L. Accurate differentiation of focal nodular hyperplasia from hepaticadenoma at gadobenatedimeglumine-enhanced MR imaging: prospective study/ L. Grazioli et al. // Radiology.
- 2005. V. 236. - № 1. - Р. 166-177.91.Guzman, G. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma / G. Guzman et al. // Arch. Pathol. Lab.Med. - 2007. - V. 131. - P.1776-1781.92.Haber, M. Multiple focal nodular hyperplasia of the liver associated with hemihypertrophy and vascular malformations / M. Haber et al. // Gastroenterology.– 1995. - V. 108. - № 4. – Р. 1256-1262.93.Hanahan, D. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis / D. Hanahan, J. Folkman // Cell.
-1996. - V. 86. - Р. 353364.16794.Hayashi, M. Correlation between the blood supply and grade of malignancy ofhepatocellular nodules associated with liver cirrhosis: evaluation by CT duringintraarterial injection of contrast medium / M. Hayashi et al. // AJR Am JRoentgenol. - 1999. - V. 172. - Р. 969-976.95.Hayashi, M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material / M. Hayashi et al. // Radiology. - 2002.
- V. 225. Р. 143-149.96.Hillen, F. Tumour vascularization: sprouting angiogenesis and beyond / F. Hillen, A.W. Griffioen // Cancer Metastasis Rev. - 2007. - V.26. - P. 489-502.97.Himeno, H. Hitherto unrecognized arterioles within hepatocellular carcinoma /H.
Himeno et al. // J. Pathol. - 1994. - V.174. - P. 217-222.98.Hlatky, L. Clinical application of antiangiogenic therapy: microvessel density,what it does and doesn't tell us / L. Hlatky, P. Hahnfeldt, J. Folkman // J. Natl.Cancer Inst. - 2002. - V. 94, - №. 12. - P. 883-893.99.Ho, J.W. Clinicopathological and prognostic implications of endoglin (CD105)expression in hepatocellular carcinoma and its adjacent non-tumorous liver /J.W.
Ho et al. // World J. Gastroenterol. - 2005. - V. 11. - № 2. - P. 176-181.100. Honda, H. Characteristic findings of hepatocellular carcinoma: an evaluationwith comparative study of US, CT, and MRI / H. Honda et al. // GastrointestRadiol. – 1992.
- V. 17. - Р. 245-249.101. Hussain, S.M. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis / S.M. Hussain et al. // Radio Graphics.- 2004. - V. 24. - Р. 3-17.102. Iannaccone, R. Hepatocellular carcinoma in patients with nonalcoholic fattyliver disease: helical CT and MR Imaging with clinical-pathologic correlationfindings / R. Iannaccone et al. // Radiology. - 2007. - V. 243. - Р. 422-430.103. Ichida, T. Subcellular abnormalities of liver sinusoidal lesions in humanhepatocellular carcinoma / T.Ichida et al.
// J. Submicrosc. Cytol. Pathol. 1990. - V.22. - P.221-229.168104. Ichikawa, T. Hepatocellular adenoma: multiphasic CT and histopathologicfindings in 25 patients / T.Ichikawa et al. // Radiology. - 2000. - V.214. - Р.861-868.105. Ishak, K.G., Goodman Z.D., Stocker J.T.
Tumors of the liver and intrahepatic bile ducts K.G. Ishak, Z.D. Goodman, J.T. Stocker // Atlas of Tumor Pathology, Third Series, Fascicle 31. - Washington, DC: American Registry of Pathology, 1999.106. Ishigami, K. Hepatocellular carcinoma with a pseudocapsule on gadoliniumenhanced MR images: correlation with histopathologic findings / K. Ishigamiet al. // Radiology.
- 2009. - V. 250. - № 2. - Р. 435-443.107. Jang, H.J. Enhancement patterns of hepatocellular carcinoma at contrastenhanced US: comparison with histologic differentiation / H.J. Jang et al. //Radiology. - 2007. - V. 244. - P. 898-906.108.
Jang, H.-J. Imaging of focal liver lesions / H.-J. Jang, H. Yu, T.K. Kim //Semin. Roentgenol. - 2009. - V. 44. - Р. 266–282.109. Jeong, Y.Y. Small (<20 mm) enhancing hepatic nodules seen on arterialphase MR imaging of the cirrhotic liver: clinical implications / Y.Y. Jeong,D.G. Mitchell, T. Kamishima // Am. J. Roentgenol. - 2002. - V.
178. - № 6. Р. 1327-1334.110. Jung, J.O. Role of hepatic stellate cells in the angiogenesis of hepatoma /J.O. Jung et al. // Korean J. Gastroenterol. - 2003. - V.42. - P.142-148.111. Kamaya, A. Hypervascularliver lesions. Semin. / A. Kamaya et al. // Ultrasound CT MR. - 2009. - V. 30. - Р. 387-407.112.
Kamel, I.R. Comprehensive analysis of hypervascular liver lesions using 16MDCT and advanced image processing / I.R. Kamel, L.P. Lawler, E.K. Fishman // AJR. - 2004. - V. 183. - Р. 443-452.113. Kaseb, A.O. Clinical and prognostic implications of plasma insulin-likegrowth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma / A.O.
Kaseb et al. // J. Clin. Oncol. - 2011. - V.29. P.3892-3899.169114. Kehagias, D. Focal nodular hyperplasia: immaging findings / D. Kehagias etal. // Eur. Radiol. - 2001. - V. 11. - № 2. - Р. 202—212.115. Kim, S.H. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for thepreoperative detection of hepatocellular carcinoma / S.H. Kim et al. // Am. J.Roentgenol. - 2009. - V. 192. - № 6. - Р. 1675-1681.116.
Kim, Y. The role of the microenvironment in tumor growth and invasion /Y. Kim, M.A. Stolarska, H.G. Othmer // Prog. Biophys. Mol. Biol. - 2011. - V.106. - № 2. - Р. 353-379.117. Kimura, H. Angiogenesis in hepatocellular carcinoma as evaluated by CD34immunohistochemistry / H. Kimura et al. // Liver. - 1998. - V. 18. - Р. 14-19.118. Kin, M. Sinusoidal capillarization in small hepatocellular carcinoma / M.Kin et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
